IL-2, TNF-α, and leptin: Local versus systemic concentrations in NSCLC patients

Oncology Research

Volumn 16, Issue 8, 2007, Pages 375-381

  Carpagnano, Giovanna E ^a   Spanevello, Antonio ^b   Curci, Claudia ^a   Salerno, Francesco ^b   Palladino, Grazia P ^a   Resta, Onofrio ^c   Di Gioia, Giuseppe ^c   Carpagnano, Francesco ^d   Foschino Barbaro, Maria P ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b IRCCS   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d SAN PAOLO HOSPITAL   (Italy)

Author keywords

Exhaled breath condensate; IL 2; Leptin; Non small cell lung cancer (NSCLC); Systemic circle; TNF

Indexed keywords

INTERLEUKIN 2; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; PROTEIN URINE LEVEL; URINALYSIS;

EID: 34548687010     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000006783980900     Document Type: Article

References (22)

1. McKeown, D. J.; Brown, D. J. F.; Kelly, A.; Wallace, A. M.; McMillan, D. C. The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer. Br. J. Cancer Res. 91:1993-1995; 2004.
2. Petty, T. L. Screening strategies for early detection of lung cancer. JAMA 284:1977-1980; 2000.
3. International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N. Engl. J. Med. 355(17):1763-1771; 2006.
4. Carpagnano, G. E.; Foschino-Barbaro, M. P.; Mulé, G.; Resta, O.; Tommasi, S.; Mangia, A.; Carpagnano, F.; Stea, G.; Susca, A.; Di Gioia, G.; De Lena, M.; Paradiso, A. 3p microsatellite alterations in exhalated breath condensate from non-small cells lung cancer patients. Am. J. Respir. Crit. Care Med. 172(6):738-744; 2005.
5. Petty, T. Early diagnosis of lung cancer. Hospital Practice; May 15, 2001
6. Neuner, A.; Schindel, M.; Wildenberg, U.; Muley, T.; Lahm, H.; Fisher, J. R. Prognostic significance of citokine modulation in non-small cell lung cancer. Int. J. Cancer 101:287-292; 2002.
7. Mazzoccoli, G.; Grilli, M.; Carughi, S.; Puzzolante, F.; De Cata, A.; La Viola, M.; Giuliani, A.; Urbano, N.; Tarquini, R.; Perfetto, F. Immune system alterations in lung cancer patients. Int. J. Immunopathol. Pharmacol. 16:167-174; 2003.
8. Orditura, M.; Romano, C.; De Vita, F.; Galizia, G.; Lieto, E.; Infusino, S.; De Cataldis, G.; Catalano, G. Behaviour of interleukin-2 serum levels in advanced non-small cells lung cancer patients: Relationship with response to therapy and survival. Cancer Immunol. Immunother. 49:530-536; 2000.
9. Cembrzynska-Novak, M.; Bienkowska, M.; Szklarz, E. Exogenous interleukin 2 regulates interleukin 6 and nitric oxide but not interferon γ and tumour necrosis factor-α production in bronchoalveolar leukocytes from patients with small cells lung cancer. Arch. Immunol. Ther. Exp. 46:367-374; 1998.
10. Naumnik, W.; Chyczewska, E. The clinical significance of serum soluble interleukin 2 receptor (sIL-2R) concentration in lung cancer. Folia Histochem. Cytobiol. 39(Suppl. 2):185-186; 2001.
11. Gridley, D. S.; Bonnet, R. B.; Bush, D. A.; Franke, C.; Cheek, G. A.; Slater, J. D.; Slater, J. M. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small cells lung cancer. Int. J. Radiat. Biol. Phys. 60:759-766; 2004.
12. Boldrini, L.; Gisfredi, S.; Ursino, S.; Lucchi, M.; Melfi, F.; Mussi, A.; Basolo, F.; Fontanini, G. Tumour necrosis factor-alpha: Prognostic role and relationship with interleukin-8 and endothelin-1 in non-small cell lung cancer. Int. J. Mol. Med. 17(5):887-892; 2006.
13. Aleman, M. R.; Santolaria, F.; Batista, N.; de la Vega, M. J.; Gonzales-Reimers, E.; Milena, A.; Llanos, M.; Gomes-Sirvent, J. L. Leptin role in advanced lung cancer. A madiator of the acute phase response or a marker of the status of nutrition? Cytokine 19(1):21-26; 2002.
14. Friedman, J. M. The function of leptin in nutrition, weight, and physiology. Nutr. Rev. 60:S1-14, 68-84, 85-87; 2002.
15. American Join Committee on Cancer Staging Handbook, 5th ed. Philadelphia: Lipincott-Raven; 1998:117-129.
16. National Heart, Lung, and Blood Institute. Workshop summary and guidelines: Investigative use of bronchoscopy, lavage and bronchial biopsy in asthma and other airway disease. J. Allergy Clin. Immunol. 88:808-814; 1992.
17. Spanevello, A.; Confalonieri, M.; Sulotto, F.; Romano, F.; Balzano, G.; Migliori, G. B.; Bianchi, A.; Michetti, G. Induced sputum cellularity. Reference values and distribution in normal volunteers. Am. J. Respir. Crit. Care Med. 162:1172-1174; 2000.
18. Bland, J. M.; Altman, D. G. Statistics Notes: Measurement error. BMJ 313:744; 1996.
19. Chyczewska, E.; Mroz, R. M.; Kowal, E. IL-2 concentration in bronchoalveolar lavage fluid (BALF) of non-small cells lung cancer (NSCLC) patients. Rocz. Akad. Med. Bialymst. 42(Suppl. 1):136-145; 1997.
20. Chyczewska, E.; Mroz, R. M.; Kowal, E. TNF-α, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC). Rocz. Akad. Med. Bialymst. 42(Suppl. 1):123-135; 1997.
21. Tran, T. A.; Kallakury, B. V.; Ambros, R. A.; Ross, J. S. Prognostic significance of tumour necrosis factors and their receptors in non-small cell lung carcinoma. Cancer 83(2):276-282; 1998.
22. Tas, F.; Duranyildiz, D.; Argon, A.; Oguz, H.; Camlica, H.; Yasasever, V.; Topuz, E. Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer. Med. Oncol. 22(4):353-358; 2005.